Nucleotide sequence, fiber2 protein, expression method of fiber2 protein and duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine

A duck Tembusu virus and dual inactivated vaccine technology, which is applied in vaccines, viruses, viral peptides, etc., can solve the problems of easy pollution, high vaccine cost, complicated process, etc., and achieve the goal of avoiding stress and high protein content Effect

Pending Publication Date: 2021-12-28
WUHAN KEQIAN BIOLOGY CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, there is only a single cell vaccine related to duck type 3 adenovirus (DAdV) vaccine, and duck Tembusu virus vaccine has only a single vaccine; as the duck type 3 adenovirus vaccine announced in patent CN108330108A, it is produced in primary duck embryo fibroblast (DEF Duck adenovirus type 3 and duck adenovirus type 2 GR strains have the highest homology, because it has been reported that the isolates of duck adenovirus type II can inactivate in primary duck embryo fibroblasts Proliferation, causing obvious cell lesions, so the virus liquid is harvested in the expanded culture of the passable duck embryo fibroblasts to obtain the virus liquid with the best virus toxicity. The preparation of primary DEF cells is complicated, easy to pollute, and costly; and At present, there are only studies and immune efficacy evaluations on duck adenovirus type 3 and duck T

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleotide sequence, fiber2 protein, expression method of fiber2 protein and duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine
  • Nucleotide sequence, fiber2 protein, expression method of fiber2 protein and duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine
  • Nucleotide sequence, fiber2 protein, expression method of fiber2 protein and duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0043] 1. Isolation and identification of duck adenovirus type 3 HB20 strain

[0044]The duck adenovirus type 3 HB20 strain was isolated and identified from the liver of sick ducks collected from a duck factory in Hubei in 2020.

[0045] The specific process is as follows:

[0046] a. RT-PCR detection of clinical disease materials

[0047] Aseptically collect the dead duck liver, cut it into pieces and add sterilized phosphate buffer solution at a ratio of 1:4 (v / v). After repeated freezing and thawing for 3 times, centrifuge at 12000r / min for 5min, take the supernatant and add green chain Mycin, the final concentration is 10000 units / ml, 4 ℃ for 2 hours. Use a 0.22 μm filter to filter and sterilize, take the filtrate to extract DNA according to the instruction manual of Sangon Biotech Genomic Nucleic Acid Extraction Kit, design primers according to the fiber2 gene of duck adenovirus type 3 published on NCBI, and carry out PCR amplification identification. The sequences of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a nucleotide sequence, a fiber2 protein, an expression method of the fiber2 protein and a duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine. The nucleotide sequence is used for coding the duck type 3 adenovirus antigenic fragment fiber2 protein, the nucleotide sequence is shown as SEQ NO:2, and the amino acid sequence of the duck type 3 adenovirus antigenic fragment fiber2 protein is shown as SEQ NO:3; a fiber2 protein gene segment and a pET-32a vector segment are connected through T4DNA ligase to obtain a pET-32a-fiber2 recombinant expression vector, then the pET-32a-fiber2 recombinant expression vector is converted into an expression strain E.coli BL-21 (DE3) competent cell for cultivation, and the fiber2 protein and the duck type 3 adenovirus and duck tembusu virus bivalent inactivated vaccine are obtained from culture; used antigens of the bivalent inactivated vaccine comprise the duck type 3 adenovirus antigenic fragment fiber2 protein and inactivated duck tembusu viruses; and the volume ratio of the two antigens in the bivalent inactivated vaccine is 1:1, the duck tembusu viruses are duck tembusu virus DF2 strains, and the preservation number of the duck tembusu virus DF2 strain is CCTCC NO: V201635.

Description

technical field [0001] The invention belongs to the field of biotechnology, and specifically relates to a nucleotide sequence, a fiber2 protein and an expression method, and a double inactivated vaccine of duck type 3 adenovirus and duck Tembusu virus. Background technique [0002] At present, there is only a single cell vaccine related to duck type 3 adenovirus (DAdV) vaccine, and duck Tembusu virus vaccine has only a single vaccine; as the duck type 3 adenovirus vaccine announced in patent CN108330108A, it is produced in primary duck embryo fibroblast (DEF Duck adenovirus type 3 and duck adenovirus type 2 GR strains have the highest homology, because it has been reported that the isolates of duck adenovirus type II can inactivate in primary duck embryo fibroblasts Proliferation, causing obvious cell lesions, so the virus liquid is harvested in the expanded culture of the passable duck embryo fibroblasts to obtain the virus liquid with the best virus toxicity. The preparati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/34C12N15/70A61K39/235A61K39/12A61P31/14
CPCC07K14/005C12N15/70A61K39/12A61P31/14C12N2710/10222C12N2710/10234C12N2770/24134A61K2039/5252A61K2039/552A61K2039/70
Inventor 金梅林姚蓉徐巧霞康超邓明勇黄运福杭尧李国红王珊
Owner WUHAN KEQIAN BIOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products